[Serious QT interval prolongation associated with velafaxine administration].

Authors :: Rubio Álvaro N
Tejedor Prado P
Hidalgo Correas FJ
García Diaz B
Source :: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2014 Sep 16; Vol. 38 (5), pp. 445-6. Date of Electronic Publication: 2014 Sep 16.
Publication Year :: 2014

Subjects :: Acute Coronary Syndrome diagnosis
Acute Coronary Syndrome drug therapy
Adult
Cardiovascular Agents therapeutic use
Diagnostic Errors
Drug Substitution
Electrocardiography
Humans
Long QT Syndrome diagnosis
Male
Sertraline therapeutic use
Sodium Channel Blockers adverse effects
Tachycardia, Sinus chemically induced
Tachycardia, Sinus diagnosis
Tachycardia, Sinus drug therapy
Antidepressive Agents adverse effects
Long QT Syndrome chemically induced
Venlafaxine Hydrochloride adverse effects

Language :: Spanish; Castilian
ISSN :: 2171-8695
Volume :: 38
Issue :: 5
Database :: MEDLINE
Journal :: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Publication Type :: Editorial & Opinion
Accession number :: 25344139
Full Text :: https://doi.org/10.7399/fh.2014.38.5.7537